Adults younger than 65 years with esophageal cancer were extremely unlikely to have a previous diagnosis of eosinophilic ...

LGK-974 is under clinical development by Novartis and currently in Phase I for Esophageal Squamous Cell Carcinoma (ESCC).

Sacituzumab govitecan is under clinical development by Gilead Sciences and currently in Phase II for Esophageal Cancer.

More research is needed to refine treatment strategies and identify predictive biomarkers for patient selection, according to researchers.

The singer mentioned that his hiatal hernia got complicated, leading to Barrett's esophagus and subsequently cancer ...

Gastrointestinal cancers, including colorectal, liver, pancreatic, esophageal, and stomach, are projected to increase over ...

This page includes links to articles highlighting the top gastrointestinal cancer research published on Cancer Therapy ...

The Food and Drug Administration (FDA) has approved Tevimbra (tislelizumab-jsgr) in combination with platinum and ...

Opdivo Qvantig is approved for solid tumors, including melanoma, renal cell carcinoma, and non-small cell lung cancer. The ...

Shares of Bristol Myers Squibb ($BMY) were in the spotlight on Friday after the U.S. Food and Drug Administration approved an ...